Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone

PHASE3CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Type 2 Diabetes
Interventions
DRUG

Saxagliptin

Tablets, Oral, 5mg, once daily, 4 weeks

DRUG

Placebo

Tablets, Oral, 0 mg, once daily, 4 weeks

Trial Locations (27)

1800

Local Institution, Marikina City

6000

Local Institution, Cebu City

10019

Clinilabs, Inc., New York

20132

Local Institution, Milan

20230

Local Institution, Aguascalientes

30076

Endocrine Research Solutions, Inc., Roswell

30513

River Birch Research Alliance, Llc, Blue Ridge

44281

Local Institution, Kfar Saba

49007

Jasper Clinic, Inc., Kalamazoo

58100

Local Institution, Holon

64460

Local Institution, Monterrey

70300

Local Institution, Ẕerifin

78229

Dgd Research, Inc., San Antonio

84047

Avastra Clinical Trials, Midvale

85013

Dedicated Phase I, Inc., Phoenix

91120

Local Institution, Jerusalem

92026

Amcr Institute, Inc, Escondido

92373

Pacific Sleep Medicine Services (Avastra Clinical Trials), Redlands

92618

Irvine Center For Clinical Research, Inc., Irvine

92701

Advantage Clinical Research, Santa Ana

92780

Orange County Research Center, Tustin

97239

Covance Cru, Inc., Portland

B1640AOD

Local Institution, Martínez

00717

Local Institution, Ponce

221 85

Local Institution, Lund

413 45

Local Institution, Gothenburg

141 86

Local Institution, Huddinge

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY